13 Health-Care Equipment Stocks Insiders Are Buying

Before you go, we thought you'd like these...
Before you go close icon

When insiders buy shares on the open market, their companies could enjoy bullish times ahead. Corporate insiders often have the inside track on their companies' prospects, and many of them get paid largely in stock options or restricted shares. Besides, insiders probably wouldn't risk plowing too much of their own money into their own company's stock -- reducing their portfolio's diversity, and increasing its risk -- unless they thought the stock might rise.

With that in mind, I screened for companies where at least one insider made an open-market buy in the last 30 days. These 13 health-care equipment and technology stocks made the list:

Security

Net Number of Buys

No. of Shares Bought

Total Value

Market Cap (in Millions)

Quidel (NAS: QDEL)

3

120,750

$1,690,000

$453

Boston Scientific (NYS: BSX)

1

102,283

$683,000

$9,919

STAAR Surgical (NAS: STAA)

1

50,802

$281,000

$239

Sirona Dental Systems (NAS: SIRO)

1

5,000

$210,000

$2,544

SonoSite (NAS: SONO)

2

5,000

$152,000

$392

Hill-Rom Holdings (NYS: HRC)

2

4,000

$125,000

$1,898

AngioDynamics (NAS: ANGO)

2

34,220

$84,000

$351

Alere

3

26,271

$81,000

$2,118

Endologix

1

10,000

$80,000

$527

Symmetry Medical

1

3,000

$26,000

$288

Alphatec Holdings

2

41,465

$15,000

$228

Computer Programs & Systems

1

150

$9,000

$745

Antares Pharma

1

2,000

$4,000

$234

Source: Capital IQ, a division of Standard & Poor's, as of August 17, 2011.

When it comes to the number and total value of insider open-market buys, more can be better; I've sorted this table accordingly. Insiders at Quidel, which offers diagnostic test solutions, made three open-market purchases worth a total of $1,690,000. In contrast, one Antares Pharma insider spent $4,000 on open-market buys. Both are bullish signs, but the Quidel purchases look much more promising. Foolish colleague Seth Jason recently described Quidel's earnings as "outstanding", while another Fool, Brian Orelli, calls Boston Scientific a "show-me" company and questions whether recent good news is sustainable. Perhaps the insider that recently made a significant $683,000 open-market purchase, putting that company at No. 2 on our list, thinks it is.

Foolish takeaway
Insider buying signals that someone who should be in the know is betting that the stock will rise. You can use this list of recent insider purchases as a starting point for further research -- or a good reason to make a contrarian play.

Are these insiders right? To help you find out, the Motley Fool recently introduced a free My Watchlist feature. You can get up-to-date news and analysis by adding companies to your Watchlist now:

At the time this article was published Fool contributorCindy Johnsondoes not currently own shares of any stock in this story.Motley Fool newsletter serviceshave recommended buying shares of SonoSite. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners